blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2791161

EP2791161 - INHIBITORS OF HCV NS5A [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.12.2016
Database last updated on 24.08.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2014/43]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / BRINKMAN, John, A.
3 Glenwood Way
West Caldwell, NJ 07006 / US
02 / SARABU, Ramakanth
3 Candlewick Drive
Towaco, NJ 07082 / US
03 / SO, Sung-Sau
11 Westover Road
Verona, NJ 07044 / US
 [2014/43]
Representative(s)Halbig, Dirk
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2014/43]
Application number, filing date12799571.013.12.2012
[2016/06]
WO2012EP75322
Priority number, dateUS201161576641P16.12.2011         Original published format: US 201161576641 P
[2014/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013087743
Date:20.06.2013
Language:EN
[2013/25]
Type: A1 Application with search report 
No.:EP2791161
Date:22.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 20.06.2013 takes the place of the publication of the European patent application.
[2014/43]
Type: B1 Patent specification 
No.:EP2791161
Date:10.02.2016
Language:EN
[2016/06]
Search report(s)International search report - published on:EP20.06.2013
ClassificationIPC:C07K5/08, A61K38/06, C07D233/64, C07D237/26, A61P31/14, C07D487/04, C07D403/04, C07K5/083, C07K5/087
[2015/27]
CPC:
C07D403/14 (EP,US); A61K31/4178 (EP,US); A61K31/55 (EP,US);
A61K31/551 (EP,US); A61K38/21 (EP,US); A61K45/06 (US);
A61P31/12 (EP); A61P31/14 (EP); C07D403/04 (EP,US);
C07D487/04 (EP,US); C07D487/06 (EP,US); C07K5/0804 (EP,US);
C07K5/0808 (EP,US); C07K5/0812 (EP,US); C07K5/0821 (EP,US);
A61K38/00 (EP,US) (-)
C-Set:
A61K38/21, A61K2300/00 (EP,US)
Former IPC [2014/43]C07K5/08, A61K38/06, C07D233/64, C07D237/26, A61P31/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:HCV-NS5A-HEMMER[2015/27]
English:INHIBITORS OF HCV NS5A[2014/43]
French:INHIBITEURS DE NS5A DE VHC[2014/43]
Former [2014/43]HCV-NS5A-SHEMMER
Entry into regional phase16.07.2014National basic fee paid 
16.07.2014Designation fee(s) paid 
16.07.2014Examination fee paid 
Examination procedure16.07.2014Examination requested  [2014/43]
03.09.2014Amendment by applicant (claims and/or description)
01.07.2015Communication of intention to grant the patent
12.10.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
26.10.2015Communication of intention to grant the patent
17.11.2015Fee for grant paid
17.11.2015Fee for publishing/printing paid
17.11.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.07.2015
Opposition(s)11.11.2016No opposition filed within time limit [2017/03]
Fees paidRenewal fee
05.12.2014Renewal fee patent year 03
07.12.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.12.2012
AL10.02.2016
AT10.02.2016
BE10.02.2016
CY10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
MC10.02.2016
MK10.02.2016
NL10.02.2016
PL10.02.2016
RO10.02.2016
RS10.02.2016
SE10.02.2016
SI10.02.2016
SK10.02.2016
SM10.02.2016
BG10.05.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
[2018/46]
Former [2018/30]HU13.12.2012
AT10.02.2016
BE10.02.2016
CY10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
MC10.02.2016
MK10.02.2016
NL10.02.2016
PL10.02.2016
RO10.02.2016
RS10.02.2016
SE10.02.2016
SI10.02.2016
SK10.02.2016
SM10.02.2016
BG10.05.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2017/47]AT10.02.2016
BE10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
MC10.02.2016
NL10.02.2016
PL10.02.2016
RO10.02.2016
RS10.02.2016
SE10.02.2016
SI10.02.2016
SK10.02.2016
SM10.02.2016
BG10.05.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2017/16]AT10.02.2016
BE10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
NL10.02.2016
PL10.02.2016
RO10.02.2016
RS10.02.2016
SE10.02.2016
SI10.02.2016
SK10.02.2016
SM10.02.2016
BG10.05.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2017/03]AT10.02.2016
BE10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
NL10.02.2016
PL10.02.2016
RO10.02.2016
RS10.02.2016
SE10.02.2016
SK10.02.2016
SM10.02.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2016/50]AT10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
NL10.02.2016
PL10.02.2016
RO10.02.2016
RS10.02.2016
SE10.02.2016
SK10.02.2016
SM10.02.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2016/49]AT10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
NL10.02.2016
PL10.02.2016
RS10.02.2016
SE10.02.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2016/46]AT10.02.2016
DK10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
NL10.02.2016
PL10.02.2016
RS10.02.2016
SE10.02.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2016/39]AT10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
LV10.02.2016
NL10.02.2016
PL10.02.2016
RS10.02.2016
SE10.02.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2016/38]AT10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
NL10.02.2016
PL10.02.2016
NO10.05.2016
GR11.05.2016
IS10.06.2016
PT13.06.2016
Former [2016/36]AT10.02.2016
FI10.02.2016
HR10.02.2016
LT10.02.2016
NL10.02.2016
PL10.02.2016
NO10.05.2016
GR11.05.2016
Former [2016/35]FI10.02.2016
HR10.02.2016
NO10.05.2016
GR11.05.2016
Cited inInternational search[A]  - CORDEK, "TARGETS TO WATCH-Targeting the NS5A protein of HCV: An emerging option", DRUGS OF THE FUTURE, (201109), vol. 36, no. 9, ISSN 0377-8282, page 691, XP055036059 [A] 1-17 * figures 5, 6; table III *

DOI:   http://dx.doi.org/10.1358/dof.2011.036.09.1641618
by applicantEP0365030
 WO9740028
 WO9817679
 WO9822496
 US5807876
 WO9840381
 WO9901582
 WO9907734
 WO0006529
 WO0009543
 WO0010573
 WO0013708
 WO0018231
 US6054472
 WO0056331
 WO0132153
 WO0185172
 WO0204425
 US6344465
 WO0218369
 WO02100851
 WO02100846
 US6498178
 WO03000254
 WO03007945
 WO03010141
 WO03037893
 WO03037894
 WO03037895
 WO2005073216
 WO2005073195
 WO2007070433
 WO2008021927
    - JOURNAL OF MEDICINAL CHEMISTRY, (1986), vol. 29, no. 6, pages 1065 - 80
    - JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1: ORGANIC AND BIO-ORGANIC CHEMISTRY (1972-1999, (1983), pages 809 - 11
    - JOURNAL OF HETEROCYCLIC CHEMISTRY, (1994), vol. 31, no. 5, pages 1121 - 3
    - ATTWOOD, M. R ET AL., JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1: ORGANIC AND BIO-ORGANIC CHEMISTRY (1972-1999, (1986), pages 1011 - 19
    - FIESER; FIESER'S, Reagents for Organic Synthesis, WILEY & SONS, (1991), vol. 1-15
    - RODD'S, Chemistry of Carbon Compounds, ELSEVIER SCIENCE PUBLISHERS, (1989), vol. 1-5
    - Organic Reactions, WILEY & SONS, (1991), vol. 1-40
    - R. BARTENSCHLAGER, J VIROL., (200303), vol. 77, no. 5, pages 3007 - 19
    - J VIROL., (2001), vol. 77, pages 5352 - 59
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.